SCHEMBL9196644

SCHEMBL9196644

CN(C)CC(=O)NN=Cc1c(-c2ccccc2)nn2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.41
MAPT P10636 5/20 0.41
ALDH1A1 P00352 5/20 0.41
LMNA P02545 3/20 0.41
GAA P10253 1/20 0.41
ADORA2A P29274 2/20 0.40
ADORA2B P29275 2/20 0.40
ADORA1 P30542 2/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 1/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
KCNH2 Q12809 2/20 0.38
HDAC1 Q13547 2/20 0.38
NPSR1 Q6W5P4 1/20 0.37
MMP2 P08253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9314185 0.86 GRK2 (0.39) MAPTALDH1A1LMNAGAATP53
SCHEMBL9312998 0.83 MEN1 (0.41) EGFRMAPTALDH1A1LMNAGAA
SCHEMBL9314971 0.83 MIF (0.46) MAPTALDH1A1LMNAGAAADORA2A
SCHEMBL9314181 0.78 ADORA2A (0.51) EGFRMAPTALDH1A1LMNAGAA
SCHEMBL9193431 0.74 MEN1 (0.44) EGFRALDH1A1LMNAADORA2AADORA2B
SCHEMBL9193428 0.74 MEN1 (0.44) EGFRALDH1A1LMNAADORA2AADORA2B
Hydrochloric Acid SCHEMBL9199696 0.72 MEN1 (0.43) EGFRALDH1A1LMNAADORA2AADORA2B
Hydrochloric Acid SCHEMBL9199693 0.72 MEN1 (0.43) EGFRALDH1A1LMNAADORA2AADORA2B
SCHEMBL9201728 0.72 ADORA2A (0.53) EGFRMAPTALDH1A1ADORA2AADORA2B
SCHEMBL9201723 0.72 ADORA2A (0.53) EGFRMAPTALDH1A1ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299209-B1 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-09-13 EP disclosed
US-5179103-A Diuretics, hypotensive agents FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1993-01-12 US disclosed
US-5102878-A Treating psychological, bone, cardiovascular, blood disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 US disclosed
US-5102869-A Urogenital disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 US disclosed
US-5087629-A Diuretics, hypotensive agents; cardiotonic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-11 US disclosed
US-4994453-A Treating asthma, diabetes, obesity, immunosuppression FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-02-19 US disclosed
US-4925849-A DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-15 US disclosed
EP-0299209-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-18 EP disclosed